Literature DB >> 27344245

Towards Predicting Protective Vaccine Responses in the Very Young.

Tobias R Kollmann1, Arnaud Marchant2.   

Abstract

Infectious diseases remain a major cause of death in infancy. Vaccination is a proven-effective strategy to reduce the risk of infectious diseases. However, important gaps remain in our understanding of vaccine responses in early life. Systems vaccinology has provided new insight into mechanisms and predictors of vaccine responses. However, systems vaccinology has not yet been systematically applied to infants younger than 12 months of age. Here, we review the knowledge gained from systems vaccinology studies of vaccines that are licensed for administration to infants. We propose that systems vaccinology should be applied to age-specific studies focused on protection, to derive the necessary insight for optimal design of vaccines for the very young.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27344245     DOI: 10.1016/j.it.2016.05.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  5 in total

1.  Inflammatory responses to influenza vaccination at the extremes of age.

Authors:  Jacqueline U McDonald; Ziyun Zhong; Helen T Groves; John S Tregoning
Journal:  Immunology       Date:  2017-05-16       Impact factor: 7.397

2.  Signaling differences in peripheral blood mononuclear cells of high and low vaccine responders prior to, and following, vaccination in piglets.

Authors:  Sean Lipsit; Antonio Facciuolo; Erin Scruten; James Wilkinson; Graham Plastow; Anthony Kusalik; Scott Napper
Journal:  Vaccine X       Date:  2022-05-09

3.  Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies.

Authors:  Fumiko Endo; Tsutomu Tabata; Daichi Sadato; Machiko Kawamura; Noriyuki Ando; Keisuke Oboki; Masako Ukaji; Kaoru Kobayashi; Yukuharu Kobayashi; Tomoaki Ikeda; Futoshi Shibasaki
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

4.  Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.

Authors:  Olubukola T Idoko; Cristina Domingo; Milagritos D Tapia; Samba O Sow; Christof Geldmacher; Elmar Saathoff; Beate Kampmann
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

5.  Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy.

Authors:  Diego R Hijano; David T Siefker; Bishwas Shrestha; Sridhar Jaligama; Luan D Vu; Heather Tillman; David Finkelstein; Jordy Saravia; Dahui You; Stephania A Cormier
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.